California Public Employees Retirement System’s Lipocine LPCN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-2,706
Closed -$69K 2311
2021
Q1
$69K Hold
2,706
﹤0.01% 3493
2020
Q4
$63K Hold
2,706
﹤0.01% 3517
2020
Q3
$65K Hold
2,706
﹤0.01% 3453
2020
Q2
$58K Hold
2,706
﹤0.01% 3398
2020
Q1
$22K Hold
2,706
﹤0.01% 3329
2019
Q4
$18K Hold
2,706
﹤0.01% 3404
2019
Q3
$129K Hold
2,706
﹤0.01% 3051
2019
Q2
$90K Hold
2,706
﹤0.01% 3117
2019
Q1
$106K Hold
2,706
﹤0.01% 3049
2018
Q4
$60K Hold
2,706
﹤0.01% 3134
2018
Q3
$63K Hold
2,706
﹤0.01% 3211
2018
Q2
$60K Hold
2,706
﹤0.01% 3218
2018
Q1
$70K Hold
2,706
﹤0.01% 3185
2017
Q4
$158K Hold
2,706
﹤0.01% 3059
2017
Q3
$183K Hold
2,706
﹤0.01% 3033
2017
Q2
$185K Hold
2,706
﹤0.01% 3036
2017
Q1
$179K Hold
2,706
﹤0.01% 3067
2016
Q4
$169K Hold
2,706
﹤0.01% 3096
2016
Q3
$205K Hold
2,706
﹤0.01% 3087
2016
Q2
$140K Hold
2,706
﹤0.01% 3240
2016
Q1
$467K Hold
2,706
﹤0.01% 2750
2015
Q4
$595K Buy
+2,706
New +$568K ﹤0.01% 2687

Other funds holding LPCN

California Public Employees Retirement System's LPCN Position: Q2 2021 in Review

California Public Employees Retirement System sold out of Lipocine (LPCN) in Q2 2021, closing a stake of 2,706 shares — an estimated $69K sold.

California Public Employees Retirement System first reported a position in LPCN in Q4 2015 and held it in 22 quarters. The position peaked at $595K in Q4 2015. 32 funds tracked by Wall St. Rank hold LPCN as of Q2 2021.

  • California Public Employees Retirement System reported no remaining Lipocine position as of Q2 2021 after selling out during the quarter.
  • California Public Employees Retirement System sold 2,706 Lipocine shares in Q2 2021, an estimated $69K.
  • California Public Employees Retirement System first reported a position in Lipocine in Q4 2015 and held it in 22 quarters.
  • California Public Employees Retirement System's Lipocine position peaked at $595K in Q4 2015.
  • 32 funds tracked by Wall St. Rank held Lipocine as of Q2 2021.

Based on California Public Employees Retirement System's 13F filing for Q2 2021, filed 13 Aug 2021.